SCHEMBL7240689

SCHEMBL7240689

CCOc1ccccc1C(=O)Nc1c(C(N)=O)nn(Cc2ccccn2)c1CC

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 3/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPK1 P28482 2/20 0.44
ALOX15 P16050 1/20 0.44
GAA P10253 2/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 3/20 0.42
HCRTR1 O43613 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
KCNK3 O14649 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6332714 0.92 AURKA (0.40) RXFP1MEN1KMT2AMAPK1ALOX15
SCHEMBL6446798 0.81 PDE5A (0.39) MEN1KMT2AMAPK1ALDH1A1
SCHEMBL6356420 0.81 PDE5A (0.38) RXFP1MEN1KMT2AMAPK1ALDH1A1
SCHEMBL6802097 0.80 PDE5A (0.36) RXFP1MEN1KMT2AMAPK1ALDH1A1
SCHEMBL6444767 0.78 PDE5A (0.40) MEN1KMT2AMAPK1GAAALDH1A1
SCHEMBL6442398 0.78 KMT2A (0.40) MEN1KMT2AMAPK1ALDH1A1LMNA
SCHEMBL6199773 0.77 HDAC1 (0.43) MAPK1GAA
SCHEMBL6200638 0.77 PDE5A (0.68) RXFP1KMT2AALDH1A1
SCHEMBL6332580 0.76 PDE5A (0.57) RXFP1KMT2AALDH1A1
SCHEMBL5827229 0.75 ADRA1D (0.40) MEN1KMT2AMAPK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670366-B1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors; impotence; pyrazolo(4,3-d)pyrimidin-7-ones PFIZER INC 2003-12-30 US disclosed
EP-0995750-A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. (US) 2000-04-26 EP disclosed